These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats. Nariai T; Fujita K; Mori M; Katayama S; Hori S; Matsui K Pharmacology; 2012; 89(1-2):44-52. PubMed ID: 22302095 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Westermann D; Riad A; Richter U; Jäger S; Savvatis K; Schuchardt M; Bergmann N; Tölle M; Nagorsen D; Gotthardt M; Schultheiss HP; Tschöpe C Basic Res Cardiol; 2009 Sep; 104(5):499-509. PubMed ID: 19255799 [TBL] [Abstract][Full Text] [Related]
27. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression. Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385 [TBL] [Abstract][Full Text] [Related]
28. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Lal A; Veinot JP; Leenen FH Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497 [TBL] [Abstract][Full Text] [Related]
29. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Huang BS; White RA; Jeng AY; Leenen FH Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098 [TBL] [Abstract][Full Text] [Related]
30. Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols. López Andrés N; Tesse A; Regnault V; Louis H; Cattan V; Thornton SN; Labat C; Kakou A; Tual-Chalot S; Faure S; Challande P; Osborne-Pellegrin M; Martínez MC; Lacolley P; Andriantsitohaina R PLoS One; 2012; 7(7):e39235. PubMed ID: 22808030 [TBL] [Abstract][Full Text] [Related]
31. Reduced collagen accumulation and augmented MMP-2 activity in left ventricle of old rats submitted to high-intensity resistance training. Guzzoni V; Marqueti RC; Durigan JLQ; Faustino de Carvalho H; Lino RLB; Mekaro MS; Costa Santos TO; Mecawi AS; Rodrigues JA; Hord JM; Lawler JM; Davel AP; Selistre-de-Araújo HS J Appl Physiol (1985); 2017 Sep; 123(3):655-663. PubMed ID: 28684598 [TBL] [Abstract][Full Text] [Related]
32. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction. Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429 [TBL] [Abstract][Full Text] [Related]
33. Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Han KH; Kang YS; Han SY; Jee YH; Lee MH; Han JY; Kim HK; Kim YS; Cha DR Kidney Int; 2006 Jul; 70(1):111-20. PubMed ID: 16723984 [TBL] [Abstract][Full Text] [Related]
34. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645 [TBL] [Abstract][Full Text] [Related]
35. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129 [TBL] [Abstract][Full Text] [Related]
36. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190 [TBL] [Abstract][Full Text] [Related]
37. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related]
38. Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats. Hori Y; Yoshioka K; Kanai K; Hoshi F; Itoh N; Higuchi S Biol Pharm Bull; 2011; 34(1):61-5. PubMed ID: 21212518 [TBL] [Abstract][Full Text] [Related]
39. Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats. Michaelis M; Hofmann PJ; Götz F; Bartel C; Kienitz T; Quinkler M Horm Metab Res; 2012 Apr; 44(4):291-5. PubMed ID: 22266825 [TBL] [Abstract][Full Text] [Related]
40. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]